Alvotech (ALVO) Change in Intangibles (2022 - 2026)
Alvotech's (ALVO) quarterly Change in Intangibles came in at -$39.1 million in Q1 2026, down 21240.44% YoY from N/an in Q1 2025, and down 312.65% on a QoQ basis from -$9.5 million in Q3 2025.
Alvotech (ALVO) Change in Intangibles (2022 - 2026) Analysis & Trends
Alvotech (ALVO) has 5 years of Change in Intangibles data on file, last reported at -$39.1 million in Q1 2026.
- Quarterly Change in Intangibles fell 21240.44% year-over-year to -$39.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$63.7 million (down 1216.89% YoY) and the FY2023 annual result came in at -$13.2 million, changed N/A from the prior year.
- Change in Intangibles slipped to -$39.1 million in Q1 2026, from -$9.5 million in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of -$183000.0 in Q1 2025 to a low of -$39.1 million in Q1 2026.
- A 5-year average of -$8.0 million and a median of -$2.9 million in 2023 frame the typical range for Change in Intangibles.
- Annual changes were most pronounced in 2024 — Change in Intangibles soared 78.69% — and 2026, when it plunged 21240.44%.
- Tracing ALVO's Change in Intangibles over 5 years: stood at -$11.1 million in 2022, then declined by 19.03% to -$13.2 million in 2023, then soared by 74.78% to -$3.3 million in 2024, then sank by 183.44% to -$9.5 million in 2025, then tumbled by 312.65% to -$39.1 million in 2026.
- The last three Change in Intangibles figures came in at -$39.1 million (Q1 2026), -$9.5 million (Q3 2025), and -$15.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -310.09 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | -39.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.05 Mn |
| Mar 31, 2026 | -39.05 Mn |
| Sep 30, 2025 | -9.46 Mn |
| Sep 30, 2025 | -9.46 Mn |
| Jun 30, 2025 | -14.99 Mn |
| Jun 30, 2025 | -14.99 Mn |
| Mar 31, 2025 | -183,000.00 |
| Mar 31, 2025 | -183,000.00 |
| Dec 31, 2024 | -3.34 Mn |
| Dec 31, 2024 | -3.34 Mn |
| Sep 30, 2024 | -427,000.00 |
| Sep 30, 2024 | -427,000.00 |
| Jun 30, 2024 | -887,000.00 |
| Jun 30, 2024 | -887,000.00 |
| Mar 31, 2024 | -543,000.00 |
| Mar 31, 2024 | -543,000.00 |
| Dec 31, 2023 | -13.24 Mn |
| Dec 31, 2023 | -13.24 Mn |
| Jun 30, 2023 | -216,000.00 |
| Jun 30, 2023 | -216,000.00 |